External Infusion Pumps

External infusion pumps are covered when reasonable and necessary for specific diagnoses and drug regimens listed in the LCD (e.g., deferoxamine for chronic iron overload; certain chemotherapies; intractable cancer pain; insulin pumps for diabetes meeting specific lab/education/insulin regimen criteria; inotropes for advanced HF; epoprostenol/treprostinil for qualifying pulmonary hypertension; SCIg for specified immune indications; Parkinson’s infusion therapies; blinatumomab under cycle and UOS limits). Coverage requires device- and drug-specific HCPCS pairing, required clinical documentation (labs, education, practitioner evaluations), supplier licensing and order documentation (SWO/WOPD/POD), and adherence to coding, supply, and refill frequency limits; items or claims not meeting these criteria (including certain HCPCS/supply code combinations, unlicensed suppliers, or missing orders) will be denied.

"External infusion pumps (HCPCS E0779, E0780, E0781, E0791) are covered for administration of deferoxamine for treatment of chronic iron overload."